Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. - Wikidata - wikimedia - TriplyDB

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

http://www.wikidata.org/entity/Q36464103

about

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Acute renal injury after partial hepatectomy Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease Clinical problem solving: utility of sonography in oncologic patients Role of surgery in colorectal cancer liver metastases Hepatotoxicity Secondary to Chemotherapy Multi-modality treatment of colorectal liver metastases Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases Multisciplinary management of patients with liver metastasis from colorectal cancer Unresolved issues and controversies surrounding the management of colorectal cancer liver metastasis Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer Biochemical Parameters for Longitudinal Monitoring of Liver Function in Rat Models of Partial Hepatectomy Following Liver Injury Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.Selection for hepatic resection of colorectal liver metastases: expert consensus statement Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS study A Novel Computational Tool for Mining Real-Life Data: Application in the Metastatic Colorectal Cancer Care Setting.Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy.Sinusoidal obstruction syndrome (veno-occlusive disease) in a patient receiving bevacizumab for metastatic colorectal cancer: a case report A case of liver fibrosis with splenomegaly after oxaliplatin-based adjuvant chemotherapy for colon cancer.Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer Oxaliplatin-based chemotherapy induces extravasated platelet aggregation in the liver Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX.Successful treatment continuation with a single mild partial splenic embolization for thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced colon cancer.Borderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complications.A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases.Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients.Using a 'no drain' policy in 342 laparoscopic hepatectomies: which factors predict failure?Hepatic Lesions that Mimic Metastasis on Radiological Imaging during Chemotherapy for Gastrointestinal Malignancy: Recent Updates.Chemotherapy within 30 days prior to liver resection does not increase postoperative morbidity or mortality Toxicant-associated steatohepatitis in vinyl chloride workers.Impact of neoadjuvant chemotherapy with FOLFOX/FOLFIRI on disease-free and overall survival of patients with colorectal metastases.Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges?Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases.Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases.Surgery for colorectal liver metastases.

P2860

Q24647888-A06F5FD0-4C1A-436E-81A6-2F45765577D2 Q26740331-A1F17BA7-331B-4D23-A139-19B19A8A598F Q26774687-FE44845F-1E76-48F4-BD2A-523DA3854F03 Q26774704-02898F4A-912A-4CC9-A34C-4917B56F0E57 Q26798157-EDE74065-9553-42AC-B30E-6BED99C5D0DD Q26827538-651723B5-1A69-454C-81C9-B82ABB145C15 Q26830444-FEBA1FC4-5CD5-4F6E-AA4D-D98207493616 Q26861560-B5940561-E724-4083-8D01-6779499BE385 Q27006832-77B9D35F-D83D-45EC-B081-6F64C36C5E2F Q27014926-90E6FFB1-8A75-47FA-8FB8-AC7373F468D3 Q28067408-F38FB790-3023-4941-9AC8-DCCAD00078EC Q28069575-B98D8A5C-DA47-4070-9021-F38B29981E26 Q28085651-7A988ECA-AE5F-44FD-BD78-FBC615FF0783 Q28252307-D7147031-E7DA-4A09-8D62-5CAB416780B3 Q28534113-7BE3E229-7848-48C3-858F-38B1251C85CF Q30412709-1BA3A410-3F68-4978-9DA5-E34208FCD14C Q30415026-E4ADEEA1-C9F4-46D0-BDC5-FA4611597859 Q30563967-76312CE6-DF6A-4D33-BAB2-48E6D76462BB Q31090273-3F18639E-4FA1-481F-A108-8A3DD18F3760 Q33378977-1A359E45-0696-4482-8ADF-9D18729700F9 Q33380322-70A8E6F4-EA9A-428C-ACE0-DFB0009F645D Q33412128-B307B9F0-27B8-4A5F-AAFB-8C58E34CAA0B Q33419966-15CD38D8-E9BF-4F53-957F-532D58F09A72 Q33424109-A61BAC39-F3B0-4854-A7E4-226BEB930343 Q33429365-608B026C-5E7F-4EC5-8C05-557A651AAEC0 Q33432526-BAC7EE1F-E249-4AEA-8B40-43767A0882A0 Q33436503-35428005-567F-48D5-97CC-A7220A8A91C4 Q33448992-E7C218FA-0BED-4041-960D-14AB8D7C1806 Q33558968-B9DB372B-076F-4015-B856-E449644EEF70 Q33558993-C1E064E5-15D8-43CB-AFF5-DF0765D7405D Q33561369-62B68790-3735-40B3-80FD-63057CF0B564 Q33563623-C7F90FF3-924F-4EEE-A5CB-E57F0CDFE620 Q33606531-242D2D0C-8863-4D4B-880E-3EE992BD7B93 Q33621031-864B63E9-004A-412F-BD32-268505ABF38F Q33622791-326F645C-26F4-4C6B-AB17-AC6DF2BE038C Q33630882-0ABD3535-7148-4A09-A193-93E144E41F1C Q33660027-854ADDBE-C558-4E46-9D1D-21CCE95B8256 Q33679628-10231715-97EC-4BF8-924B-F50301EB9658 Q33690475-7C4AB613-FC65-4C5A-A8D0-38518E155D76 Q33834452-958692C4-8840-466E-8AB8-42C9BDF87829

P2860

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

http://www.wikidata.org/entity/Q36464103

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Chemotherapy regimen predicts ...... hepatic colorectal metastases.

@ast

Chemotherapy regimen predicts ...... hepatic colorectal metastases.

@en

type

label

Chemotherapy regimen predicts ...... hepatic colorectal metastases.

@ast

Chemotherapy regimen predicts ...... hepatic colorectal metastases.

@en

prefLabel

Chemotherapy regimen predicts ...... hepatic colorectal metastases.

@ast

Chemotherapy regimen predicts ...... hepatic colorectal metastases.

@en

P1433

Q36464103-BD4977FB-A14B-4B4C-97F9-763EE3640C08

P1476

Q36464103-DA30A186-13CB-4DC1-8143-67E5334209AF

P2093

Q36464103-004C9E9E-0658-43A6-A0B0-6EB4C1056221

Q36464103-0FDA4CB5-E44D-4DBE-BC05-6DD2522D43D7

Q36464103-1EDF99D9-3042-459A-9CE5-F85D10C379D0

Q36464103-2B2530EA-C236-4044-8563-3EFA9B7C28B1

Q36464103-5091CEC6-5BF2-4D0F-A4CF-E001071B54F4

Q36464103-752F4944-F430-4DA1-BE27-FC8384A76E26

Q36464103-90757F15-5B67-4FBC-9A33-665A09F3CA30

Q36464103-A4F1061B-1111-465E-8210-370C7F58E61E

Q36464103-B777D408-C832-4654-AF6D-8E7F2E8DA6CF

Q36464103-D0C970EB-C1CA-4808-8838-0DD9411F286E

P304

Q36464103-862A5D2B-D86E-43BD-A296-EEE8B5A7FF87

P31

Q36464103-DF24850F-280B-41D9-97D8-DBF4F149EC4E

P356

Q36464103-C43FA920-1878-43E0-8A02-94A98CB4A974

P407

Q36464103-A65BB58E-9CDC-4D7D-B6AD-B70A609E1DA3

P433

Q36464103-D40095DA-A83F-4512-9D29-DCFEA4AAED53

P478

Q36464103-0D2F5890-7143-4FF7-8CF9-3865FE239727

P50

Q36464103-289A93C5-4C73-4EB8-B190-D87C2A720FAE

Q36464103-C497D326-5FB8-4FBE-BEC4-D27103B4A737

Q36464103-F7F8EF52-E5FB-4F9B-85F9-564ED938163F

P577

Q36464103-4FC16583-700A-437A-9F91-963BE0DA57EB

P698

Q36464103-50C7C65C-124D-45B6-BD31-DE9BE59FD68C

P921

Q36464103-7F6AA4AA-8816-4F6E-ACAE-57FA65F83FB9

Q36464103-9CA4F424-47C7-4C51-81AC-03BB4D008167

P356

JCO.2005.05.3074

P1433

Journal of Clinical Oncology

P1476

Chemotherapy regimen predicts ...... hepatic colorectal metastases.

@en

P2093

Andrea Muratore

http://www.w3.org/2001/XMLSchema#string

Cathy Eng

http://www.w3.org/2001/XMLSchema#string

Daria Zorzi

http://www.w3.org/2001/XMLSchema#string

Dario Ribero

http://www.w3.org/2001/XMLSchema#string

Eddie K Abdalla

http://www.w3.org/2001/XMLSchema#string

Gregory Y Lauwers

http://www.w3.org/2001/XMLSchema#string

Henry Q Xiong

http://www.w3.org/2001/XMLSchema#string

Lorenzo Capussotti

http://www.w3.org/2001/XMLSchema#string

Mauro Risio

http://www.w3.org/2001/XMLSchema#string

Paulo M Hoff

http://www.w3.org/2001/XMLSchema#string

P304

2065-2072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.05.3074

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Mari Mino-Kenudson

Jean-Nicolas Vauthey

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16648507

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis